Note: Ingredients listed on restricted chemical lists
EC/CAS
93-14-1
Name of the chemical
Guaifenesin (INN)
Concentration
N/A
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
General Information
Revision date
2021-02-03
Product name
Primatene Tablets
Product Synonyms
WH-0185-0088
supplier name
GlaxoSmithKline Korea
Icons in SDS
Company Information
company name
GlaxoSmithKline Korea
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
A. Hazard category/Classification
Physical hazards
Not classified.
Health hazards
Acute toxicity, oral Category 4
Environmental hazards
Not classified. B. Warning label items including precautionary statement
Signal word
Warning
Hazard statements
H302 Harmful if swallowed.
Prevention
P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product.
Response
P301 + P312 IF SWALLOWED: Call a POISON CENTRE or doctor/physician if you feel unwell. P330 Rinse mouth.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations. C. Other hazards not included None known. in the hazard category criteria (e.g. dust explosion hazard)
Additional information
30 % of the mixture consists of component(s) of unknown acute oral toxicity. 96.1 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 91.3 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
